Four things to know:
1. Dr. Chiocca has almost 25 years of experience in neuro-oncology and neurosurgery.
2. He is the Harvey W. Cushing professor of neurosurgery at Harvard Medical School in Boston as well as neurosurgeon-in-chief and chairman of the department of neurosurgery at Brigham and Women’s Hospital, also in Boston.
3. Dr. Chiocca specializes in engineering biologic agents into selective anticancer agents, with a focus on brain tumors.
4. His work was featured in the Journal of Neurosurgery, Molecular Therapy as well as Neuro-oncology, and he served as president of the Society for Neuro-Oncology from 2015 to 2017.
More articles on devices:
‘A dream come true’: Dr. Jorge Chahla strives for success at Rush
New York hospital invests $2M in imaging system for spine, brain — 4 things to know
What Stryker’s spine division stands to gain from 5 acquisitions
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.